1887

Abstract

The rate and severity of infection (CDI) have been linked to the emergence and spread of the hypervirulent toxigenic strain NAP1/027. This strain has been responsible for large outbreaks in healthcare facilities in North America and Europe and most recently in Latin America. This is the first report of the NAP1 strain in Panama. It suggests that the spread of NAP1 throughout Latin America could be a possibility as evidenced in the following case reports. Five isolates typed as NAP1 had , , binary toxin gene and deletion. All isolates were resistant to clindamycin, fluoroquinolones and rifampicin. Under this scenario, surveillance programmes for CDI should be implemented in public health facilities in Latin America and diagnosis of CDI should be considered, especially in patients with predisposing factors.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.066399-0
2014-02-01
2019-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/2/322.html?itemId=/content/journal/jmm/10.1099/jmm.0.066399-0&mimeType=html&fmt=ahah

References

  1. Denève C., Janoir C., Poilane I., Fantinato C., Collignon A.. ( 2009;). New trends in Clostridium difficile virulence and pathogenesis. . Int J Antimicrob Agents 33: (Suppl 1), S24–S28. [CrossRef][PubMed]
    [Google Scholar]
  2. Dubberke E. R., Reske K. A., Yan Y., Olsen M. A., McDonald L. C., Fraser V. J.. ( 2007;). Clostridium difficile – associated disease in a setting of endemicity: identification of novel risk factors. . Clin Infect Dis 45:, 1543–1549. [CrossRef][PubMed]
    [Google Scholar]
  3. Freeman J., Bauer M. P., Baines S. D., Corver J., Fawley W. N., Goorhuis B., Kuijper E. J., Wilcox M. H.. ( 2010;). The changing epidemiology of Clostridium difficile infections. . Clin Microbiol Rev 23:, 529–549. [CrossRef][PubMed]
    [Google Scholar]
  4. Hecht D., Citron D. M., Cox M., Jacobus N., Jenkins S. G., Onderdonk A., Roe-Carpenter D., Rosenblatt J. E., Wexler H. M.. ( 2007;). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, , 7th edn., Clinical and Laboratory Standards Institute document M11–A7 27, 1–47. Wayne, PA:: Clinical and Laboratory Standards Institute;.
    [Google Scholar]
  5. Hernández-Rocha C., Barra-Carrasco J., Pizarro-Guajardo M., Ibáñez P., Bueno S. M., Sarker M. R., Guzmán A. M., Alvarez-Lobos M., Paredes-Sabja D.. ( 2012;). Epidemic Clostridium difficile ribotype 027 in Chile. . Emerg Infect Dis 18:, 1370–1372. [CrossRef][PubMed]
    [Google Scholar]
  6. Labbé A.-C., Poirier L., MacCannell D., Louie T., Savoie M., Béliveau C., Laverdière M., Pépin J.. ( 2008;). Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. . Antimicrob Agents Chemother 52:, 3180–3187. [CrossRef][PubMed]
    [Google Scholar]
  7. Limbago B. M., Long C. M., Thompson A. D., Killgore G. E., Hannett G. E., Havill N. L., Mickelson S., Lathrop S., Jones T. F.. & other authors ( 2009;). Clostridium difficile strains from community-associated infections. . J Clin Microbiol 47:, 3004–3007. [CrossRef][PubMed]
    [Google Scholar]
  8. Loo V. G., Poirier L., Miller M. A., Oughton M., Libman M. D., Michaud S., Bourgault A. M., Nguyen T., Frenette C.. & other authors ( 2005;). A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. . N Engl J Med 353:, 2442–2449. [CrossRef][PubMed]
    [Google Scholar]
  9. McDonald L. C., Killgore G. E., Thompson A., Owens R. C. Jr, Kazakova S. V., Sambol S. P., Johnson S., Gerding D. N.. ( 2005;). An epidemic, toxin gene-variant strain of Clostridium difficile.. N Engl J Med 353:, 2433–2441. [CrossRef][PubMed]
    [Google Scholar]
  10. Miller M., Gravel D., Mulvey M., Taylor G., Boyd D., Simor A., Gardam M., McGeer A., Hutchinson J.. & other authors ( 2010;). Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. . Clin Infect Dis 50:, 194–201. [CrossRef][PubMed]
    [Google Scholar]
  11. Morgan O. W., Rodrigues B., Elston T., Verlander N. Q., Brown D. F. J., Brazier J., Reacher M.. ( 2008;). Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. . PLoS ONE 3:, e1812. [CrossRef][PubMed]
    [Google Scholar]
  12. O’Connor J. R., Johnson S., Gerding D. N.. ( 2009;). Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. . Gastroenterology 136:, 1913–1924. [CrossRef][PubMed]
    [Google Scholar]
  13. Pépin J., Valiquette L., Alary M. E., Villemure P., Pelletier A., Forget K., Pépin K., Chouinard D.. ( 2004;). Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. . CMAJ 171:, 466–472. [CrossRef][PubMed]
    [Google Scholar]
  14. Quesada-Gómez C., Rodríguez C., Gamboa-Coronado M. M., Rodríguez-Cavallini E., Du T., Mulvey M. R., Villalobos-Zúñiga M., Boza-Cordero R.. ( 2010;). Emergence of Clostridium difficile NAP1 in Latin America. . J Clin Microbiol 48:, 669–670. [CrossRef][PubMed]
    [Google Scholar]
  15. Razavi B., Apisarnthanarak A., Mundy L. M.. ( 2007;). Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. . Infection 35:, 300–307. [CrossRef][PubMed]
    [Google Scholar]
  16. Spigaglia P., Mastrantonio P.. ( 2004;). Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. . J Med Microbiol 53:, 1129–1136. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.066399-0
Loading
/content/journal/jmm/10.1099/jmm.0.066399-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error